Adam Wiggins

Adam Wiggins is a hacker and entrepreneur. As a co-founder of Heroku he spends his days thinking about the future of application development. Follow him online at @hirodusk and http://adam.heroku.com or get in touch here.

Recent posts

Three Months in Berlin: One Tech Entrepreneur’s Journey
San Francisco is the center of the tech world. But after three months in Europe, my conclusion is that there’s a major new contender as a great place to start startups:... Read more »
Programming Literacy Done Right: It’s About the Tools
Bonnie Nardi is an anthropologist who studies interactions between humans and computers. In 1993, she published her first book, A Small Matter of Programming. The book’s thesis is bold... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Webinar
Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins Discovery

Sponsored · Webinar
Nov. 12 – High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocytes
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Eurofins DiscoverX

From Our Editors · Special Report
Xcelerating Life Sciences San Francisco: Special Report
The AI, Big Data, and R&D Boom

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Adam Wiggins

Recent posts

Three Months in Berlin: One Tech Entrepreneur’s Journey

Programming Literacy Done Right: It’s About the Tools

Underwriters and Partners

Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development

Nov. 12 – High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocytes

Xcelerating Life Sciences San Francisco: Special Report

Xconomy on Demand

We offer a number of ways to subscribe for free!